4-methyl-7-[(E)-5-(6-pyrrolidin-1-ylpurin-9-yl)pent-2-enoxy]chromen-2-one
C24H25N5O3 — CID 155563421
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-methyl-7-[(E)-5-(6-pyrrolidin-1-ylpurin-9-yl)pent-2-enoxy]chromen-2-one
4-methyl-7-[(E)-5-(6-pyrrolidin-1-ylpurin-9-yl)pent-2-enoxy]chromen-2-one (PubChem CID 155563421) has the molecular formula C24H25N5O3 and a molecular weight of 431.50 g/mol. Its IUPAC name is 4-methyl-7-[(E)-5-(6-pyrrolidin-1-ylpurin-9-yl)pent-2-enoxy]chromen-2-one.
Molecular Properties
| Compound Name | 4-methyl-7-[(E)-5-(6-pyrrolidin-1-ylpurin-9-yl)pent-2-enoxy]chromen-2-one |
|---|---|
| PubChem CID | 155563421 |
| Molecular Formula | C24H25N5O3 |
| Molecular Weight | 431.50 g/mol |
| Exact Mass | 431.20 |
| IUPAC Name | 4-methyl-7-[(E)-5-(6-pyrrolidin-1-ylpurin-9-yl)pent-2-enoxy]chromen-2-one |
| SMILES | Cc1cc(=O)oc2cc(OC/C=C/CCn3cnc4c(N5CCCC5)ncnc43)ccc12 |
| InChI | InChI=1S/C24H25N5O3/c1-17-13-21(30)32-20-14-18(7-8-19(17)20)31-12-6-2-3-11-29-16-27-22-23(25-15-26-24(22)29)28-9-4-5-10-28/h2,6-8,13-16H,3-5,9-12H2,1H3/b6-2+ |
| InChIKey | WWAHUYNBIDKTEF-QHHAFSJGSA-N |
| XLogP | 3.87 |
| TPSA | 86.28 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.50 |
| LogP ≤ 5 | 3.87 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155563421 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.